Select Medical Holdings CORP Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
Glazer Capital, LLC and Paul J. Glazer have reported beneficial ownership of 10,744,069 shares, representing 8.67% of Select Medical Holdings Corporation's common stock.
NYSE
Vanguard Portfolio Management has filed an amendment to its Schedule 13G, reporting its beneficial ownership of Select Medical Holdings Corp. common stock as of June 30, 2026.
NYSE
Glazer Capital, LLC and Paul J. Glazer have reported a beneficial ownership of 5.21% in Select Medical Holdings Corporation's common stock.
NYSE
Vanguard Portfolio Management has reported a beneficial ownership of 5.45% in Select Medical Holdings Corp. common stock as of March 31, 2026.
NYSE
T. Rowe Price Associates, Inc. has filed an amendment to its Schedule 13G, reporting beneficial ownership of 0.1% of Select Medical Holdings Corp. common stock as of March 31, 2026.
NYSE
The Vanguard Group has reported zero beneficial ownership in Select Medical Holdings Corp following an internal realignment.
NYSE
BlackRock, Inc. has filed an Amendment No. 11 to Schedule 13G, disclosing its beneficial ownership of 12.4% of Select Medical Holdings Corp.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 15.5% beneficial ownership stake in Select Medical Holdings Corp. as of December 31, 2024.
NYSE
The Estate of Rocco A. Ortenzio has filed an Amendment No. 15 to Schedule 13G, disclosing a beneficial ownership of 3.2% in Select Medical Holdings Corporation as of December 31, 2024.